Zurcher Kantonalbank Zurich Cantonalbank Has $185,000 Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) by 78.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,524 shares of the company’s stock after buying an additional 6,363 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Treace Medical Concepts were worth $185,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Van ECK Associates Corp raised its stake in shares of Treace Medical Concepts by 48.7% in the 3rd quarter. Van ECK Associates Corp now owns 4,093 shares of the company’s stock valued at $54,000 after acquiring an additional 1,340 shares in the last quarter. Spouting Rock Asset Management LLC acquired a new stake in shares of Treace Medical Concepts in the third quarter worth $148,000. Arizona State Retirement System lifted its stake in shares of Treace Medical Concepts by 17.1% in the third quarter. Arizona State Retirement System now owns 13,097 shares of the company’s stock worth $172,000 after buying an additional 1,910 shares during the last quarter. Numerai GP LLC bought a new stake in shares of Treace Medical Concepts during the 3rd quarter worth $217,000. Finally, Jump Financial LLC boosted its holdings in shares of Treace Medical Concepts by 72.1% during the 3rd quarter. Jump Financial LLC now owns 67,490 shares of the company’s stock worth $885,000 after buying an additional 28,273 shares during the period. Institutional investors and hedge funds own 84.08% of the company’s stock.

Treace Medical Concepts Price Performance

NASDAQ TMCI opened at $11.12 on Wednesday. The company has a current ratio of 4.40, a quick ratio of 3.76 and a debt-to-equity ratio of 0.38. The company has a fifty day simple moving average of $12.07 and a 200 day simple moving average of $11.72. The company has a market cap of $686.77 million, a P/E ratio of -13.75 and a beta of 0.37. Treace Medical Concepts, Inc. has a 1 year low of $5.27 and a 1 year high of $27.70.

Treace Medical Concepts (NASDAQ:TMCI) last posted its quarterly earnings data on Tuesday, February 27th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by ($0.01). The firm had revenue of $62.20 million for the quarter, compared to the consensus estimate of $60.56 million. Treace Medical Concepts had a negative return on equity of 33.96% and a negative net margin of 26.47%. Treace Medical Concepts’s quarterly revenue was up 24.9% on a year-over-year basis. During the same period in the prior year, the company posted ($0.08) earnings per share. On average, sell-side analysts predict that Treace Medical Concepts, Inc. will post -0.91 EPS for the current year.

About Treace Medical Concepts

Treace Medical Concepts, Inc, a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity.